Dainippon Sumitomo Pharma's (DSP) US subsidiary, Sepracor, is to change its operating name to Sunovion Pharmaceuticals by the end of this year.
The commercial functions and product portfolio of the company will otherwise remain unchanged, and the operation will maintain its current headquarters in Marlborough, Massachusetts. R&D activities will be conducted both...